Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples